These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37873794)

  • 1. A Review of Hematological Complications and Treatment in COVID-19.
    Yazdani AN; Abdi A; Velpuri P; Patel P; DeMarco N; Agrawal DK; Rai V
    Hematol Rep; 2023 Oct; 15(4):562-577. PubMed ID: 37873794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse Hematological Effects of COVID-19 Vaccination and Pathomechanisms of Low Acquired Immunity in Patients with Hematological Malignancies.
    Yazdani AN; DeMarco N; Patel P; Abdi A; Velpuri P; Agrawal DK; Rai V
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematological Questions in Personalized Management of COVID-19 Vaccination.
    Wu T; Li J; Hu Y; Tang LV
    J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological and Hematological Response in COVID-19.
    Słomka A; Martucci G; Raffa GM; Malvindi PG; Żekanowska E; Lorusso R; Suwalski P; Kowalewski M
    Adv Exp Med Biol; 2021; 1352():73-86. PubMed ID: 35132595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis.
    Jafari M; Dastgheib SA; Ferdosian F; Mirjalili H; Aarafi H; Noorishadkam M; Mazaheri M; Neamatzadeh H
    Hematol Transfus Cell Ther; 2022; 44(2):225-234. PubMed ID: 34931178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematological Profile in COVID-19 Infection Among Patients in a Tertiary Care Hospital in Tamil Nadu, South India.
    Chandran N; Sigamani K; Khadeja Bi A
    Cureus; 2022 Oct; 14(10):e30731. PubMed ID: 36457636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience.
    Weinbergerová B; Demel I; Víšek B; Válka J; Čerňan M; Jindra P; Novák J; Stejskal L; Kovácsová F; Kabut T; Szotkowski T; Hájek R; Žák P; Cetkovský P; Král Z; Mayer J
    Hematol Oncol; 2022 Apr; 40(2):280-286. PubMed ID: 35120267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematological changes associated with COVID-19 infection.
    Al-Saadi EAKD; Abdulnabi MA
    J Clin Lab Anal; 2022 Jan; 36(1):e24064. PubMed ID: 34783405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Convalescent Plasma Therapy in COVID-19 Patients with Hematological Malignancies: A Systematic Review.
    Shibeeb S; Ajaj I; Al-Jighefee H; Abdallah AM
    Hematol Rep; 2022 Dec; 14(4):377-388. PubMed ID: 36547236
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 and chronic myeloid leukemia: a systematic review.
    Ali EA; Al-Sadi A; Al-Maharmeh Q; Subahi EA; Bellamkonda A; Kalavar M; Panigrahi K; Alshurafa A; Yassin MA
    Front Med (Lausanne); 2023; 10():1280271. PubMed ID: 38327268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.
    Civriz Bozdağ S; Cengiz Seval G; Yönal Hindilerden İ; Hindilerden F; Andıç N; Baydar M; Aydın Kaynar L; Toprak SK; Göksoy HS; Balık Aydın B; Demirci U; Can F; Özkocaman V; Gündüz E; Güven ZT; Özkurt ZN; Demircioğlu S; Beksaç M; İnce İ; Yılmaz U; Eroğlu Küçükdiler H; Abishov E; Yavuz B; Ataş Ü; Mutlu YG; Baş V; Özkalemkaş F; Üsküdar Teke H; Gürsoy V; Çelik S; Çiftçiler R; Yağcı M; Topçuoğlu P; Çeneli Ö; Abbasov H; Selim C; Ar MC; Yücel OK; Sadri S; Albayrak C; Demir AM; Güler N; Keklik M; Terzi H; Doğan A; Yegin ZA; Kurt Yüksel M; Sadri S; Yavaşoğlu İ; Beköz HS; Aksu T; Maral S; Erol V; Kaynar L; İlhan O; Bolaman AZ; Sevindik ÖG; Akyay A; Özcan M; Gürman G; Ünal Ş; Yavuz Y; Diz Küçükkaya R; Özsan GH
    Turk J Haematol; 2022 Feb; 39(1):43-54. PubMed ID: 34521187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes.
    Guo W; Zheng Y; Feng S
    Front Cell Infect Microbiol; 2023; 13():1207225. PubMed ID: 37928188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
    Reis S; Metzendorf MI; Kuehn R; Popp M; Gagyor I; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015395. PubMed ID: 36126225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematological manifestations of COVID-19.
    Mina A; van Besien K; Platanias LC
    Leuk Lymphoma; 2020 Dec; 61(12):2790-2798. PubMed ID: 32643489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 in Adult Patients with Hematological Malignancies-Lessons Learned after Three Years of Pandemic.
    Hus I; Szymczyk A; Mańko J; Drozd-Sokołowska J
    Biology (Basel); 2023 Apr; 12(4):. PubMed ID: 37106746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroconversion in hematology-oncology patients.
    Bird PW; Badhwar V; Kennedy B; Ladani S; Tang JW
    J Med Virol; 2021 Jul; 93(7):4585-4591. PubMed ID: 33595119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic profile and clinical implications of hematological and immunological parameters in COVID-19 patients. A retrospective study.
    Suryawanshi SY; Priya S; Sinha SS; Soni S; Haidry N; Verma S; Singh S
    J Family Med Prim Care; 2021 Jul; 10(7):2518-2523. PubMed ID: 34568129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan".
    Zaki A; Soomar SM; Khan DH; Shaharyar Sheikh H; Iftikhar R; Mir A; Aziz Z; Bano K; Naseer H; Chaudhry QU; Bokhari SWI; Shabbir-Moosajee M
    PLoS One; 2022; 17(4):e0267139. PubMed ID: 35446898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature.
    Eslait-Olaciregui S; Llinás-Caballero K; Patiño-Manjarrés D; Urbina-Ariza T; Cediel-Becerra JF; Domínguez-Domínguez CA
    Ther Adv Drug Saf; 2023; 14():20420986231165674. PubMed ID: 37223456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.